Aerie Pharmaceuticals
Data Breaches, Cyber Attacks and Security Report

https://aeriepharma.com ᛫
Last updated November 16, 2019

About Aerie Pharmaceuticals

Company Overview

Aerie Pharmaceuticals Inc. (NASDAQ: AERI) is a publicly traded, clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

Valuation

Employees

CEO

Location

Data Breaches and Security News

Aerie Pharmaceuticals Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Aerie Pharmaceuticals is implementing good security practices.